Marta Chiaravalli
Università Cattolica del Sacro Cuore(IT)Agostino Gemelli University Polyclinic(IT)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Renal cell carcinoma treatment, Neuroendocrine Tumor Research Advances, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial(2018)250 cited
- → Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies(2017)133 cited
- → Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma(2017)110 cited
- → Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial(2018)68 cited
- → Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives(2018)59 cited
- → A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma(2018)57 cited
- → Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers(2022)45 cited
- → Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis(2024)31 cited
- → Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification(2020)20 cited
- → Real‐World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1‐2 Pathogenic Variants(2025)4 cited